Pulmonx Corporation · NASDAQ:LUNG
Soleus Capital Master Fund, L.P. reported a 6.50% stake in Pulmonx Corporation (Schedule 13G)
Event Mar 6, 2026 · Filed Mar 9, 2026
Soleus Capital Master Fund, L.P. reported a 6.50% stake in Pulmonx Corporation, 2,665,100 shares, as a passive investor on Mar 6, 2026. Filed Mar 9, 2026 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 2,665,100
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 6.50% | 2,665,100 |
| Soleus Capital, LLC | 6.50% | 2,665,100 |
| Soleus Capital Group, LLC | 6.50% | 2,665,100 |
| Soleus Capital Management, L.P. | 6.50% | 2,665,100 |
| Soleus GP, LLC | 6.50% | 2,665,100 |
| Guy Levy | 6.50% | 2,665,100 |
Source
Related
- Pulmonx Corporation
- Soleus Capital Master Fund, L.P.
- Pulmonx Corporation shareholders
- Form 4 · French Glendon E. III · Sep 3, 2026
- Form 4 · Radhakrishnan Srikanth · Sep 3, 2026
- Form 4 · Lehman David Aaron · Sep 3, 2026
- Form 4 · Rose Geoffrey Beran · Sep 3, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026